View more job listings or post a job
Jazz Pharmaceuticals Head of Toxicology
Dow Development Laboratories Formulation Chemist
Genentech Scientist, DMPK
Pliant Therapeutics, Inc. Associate Director/ Director, Formulation Development
AbVision Inc. Research Scientist (Immunology/Cell Biology, all levels available)
Regulus Therapeutics Senior Research Associate/Scientist, Drug Metabolism and Pharmacokinetics
Aligos Therapeutics Principal Research Scientist, DMPK
Post a job


Tox 21 and New Approach Methodology (NAMs): Using Emerging Technologies to Improve Translational Research and Safety Assessment Predictions (jointly by SOT-NorCal & PBSS)

Speakers: Kathryn Page (Clorox); Shichang Miao (ChemoCentryx); Thomas Hartung (The Bloomberg School of Public Health); Emily Reinke (U.S. Army Public Health Center); Suzanne Fitzpatrick (FDA); Pamela Lein (UC Davis); Ellen Berg (Eurofins); Will Proctor (Genentech)
Date: 2019-04-25
Time: 8:30-17:00 Pacific Time
Registration fee (USD): Regular (with lunch): $60; Students & Postdocs (with lunch): $0
Location: South San Francisco Conference Center
Major Sponsor:
Vendor show vendors registered to date:
Registration deadline:2019-04-23  (it will close sooner if the seating cap is reached)

About the Topic

Preliminary Agenda

Morning Session

7:30 am – 8:30 am          Registration & Breakfast

8:30 am – 8:45 am          Opening message from The NorCal & PBSS Presidents - Kathryn Page, PhD, DABT, Clorox; Shichang Miao, PhD, ChemoCentryx

8:45 am – 9:30 am          Plenary Speaker:  Alternative Methods for the 21st Century - Thomas Hartung, PhD, Johns Hopkins Bloomberg School of Public Health

9:30 am – 10:15 am        From Experimental Concept to Regulatory Acceptance:  The Success of Alternative Methods in Skin Sensitization Testing - Emily Reinke, PhD, DABT, U.S. Army Public Health Center

10:15 am – 10:30 am     Coffee Break

10:30 am – 11:15 am     Consumer Product Safety Assessment: An Alternative Approach - Kathryn Page, PhD, DABT, Clorox

11:15 am – 12:00 pm     Predictive Toxicology for Regulatory Decisions:  Implementing New Approaches at FDA - Suzanne Fitzpatrick, PhD, FDA

12:00 pm – 1:30 pm       Lunch Break: Lunch with Experts, Posters

Afternoon Session

1:30 pm – 1:45 pm         Chapter announcements and acknowledgements

1:45 am – 2:05 am          NorCal Student Award presentation: TBD

2:05 pm – 2:45 pm         In Vitro and Alternative Models of Neurotoxicity:  Opportunities and Challenges for Neurotoxicity Testing - Pamela Lein, PhD, DABT, UC Davis

2:45 pm – 3:00 pm         Coffee Break

3:00 pm – 3:45 pm         Applying Human-based Phenotypic Profiling in Early Drug Discovery - Ellen Berg, PhD, Eurofins

3:45 pm – 4:30 pm         Industry Perspective on Evaluating, Qualifying, and Implementing Complex In Vitro Models to Support Drug Discovery - Will Proctor, PhD, DABT, Genentech

4:30 pm – 6:00 pm         Reception & Networking

2019-07-26, Generating Efficacious Enzyme Therapeutics based on Knowledge Learned From Biocatalytic Pharmaceutical Manufacture
2019-09-13, Biotransformation and Disposition of Larger Molecules: Peptides, Nucleotides, Proteins, mAbs, and ADCs
2019-10-03, Small-Molecule Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends
2019-10-18, Physiologically Based Pharmacokinetic (PBPK) Modeling: Fundamentals, Regulatory Guidance & Applications
2019-11-12, Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
2019-12-10, In Vitro Diagnostics, Companion Diagnostics and Precision Medicine
2020-02-11, Drug-Device Combination
2020-05-12, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
┬ęPharmaceutical & BioScience Society, International; Last Modified: 7/22/2019; Visited: 391; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

XCELERATE at Biotech Week Boston Driving the Future of the Life Science Industry. Sept. 11 at BCEC. Learn more.
Hypha Discovery mg-g scale synthesis/purification of CYP/non-CYP metabolites including glucuronides. Plus NEW PolyCYPs kits for in-house synthesis of CYP metabolites.
BIOTECH WEEK BOSTON - Sept. 9-12 Access over 5,000 of the most innovative scientific minds & business leaders in Boston and around the world. Learn More.
UC Davis UC Davis LC/MS Confirmation Supervisor (Lab Rsch Supv 2) Apply Online: UC Davis is an AA/EOE
Pacific BioLabs CRO in Bay Area - PK, toxicology, biocompatibility, analytical chemistry, immunogenicity, biomarker analysis, stability studies, sterility, endotoxin
Submit a Text Ad